Combatting Counterfeits In The Biopharma Supply Chain
Source: Life Science Leader
In this executive virtual roundtable (EVR) section, Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics, shares his thoughts on combatting counterfeits in the biopharmaceutical supply chain, recommending Rx-360 as a resource for the latest information on combatting biopharma counterfeits. Bryan Butman, Ph.D., head of CMC, Precigen, adds to the conversation.
This website uses cookies to ensure you get the best experience on our website. Learn more